Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TDOC
TDOC logo

TDOC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.280
Open
7.200
VWAP
7.21
Vol
321.46K
Mkt Cap
1.31B
Low
7.150
Amount
2.32M
EV/EBITDA(TTM)
7.35
Total Shares
180.51M
EV
1.55B
EV/OCF(TTM)
5.40
P/S(TTM)
0.51
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
Show More

Events Timeline

(ET)
2026-04-29
19:50:00
WTI Crude Oil Rises Above $108 for Third Consecutive Day
select
2026-04-29
16:20:00
Sees FY26 Revenue of $2.481B-$2.576B
select
2026-04-29
16:20:00
Teladoc Health Reports Q1 Revenue of $613.8M
select
2026-04-29
16:20:00
Company Sees Q2 Revenue of $597M-$626M
select
2026-04-29
14:20:00
Notable Companies Earnings Consensus: Alphabet $2.63
select

News

seekingalpha
2.0
05-08seekingalpha
Teladoc Health Shares Rise for Seven Consecutive Days
  • Stock Price Surge: Teladoc Health's shares rose over 4% on Friday, marking a seven-day winning streak, with a 22% increase since April 30, climbing from $5.95 to approximately $7.30, indicating strong market optimism about its future prospects.
  • Strong Monthly Performance: Over the past month, Teladoc's stock has gained 38%, although it is up only 2.7% year-to-date, trailing the S&P 500's approximately 7% gains, reflecting a need for improvement in its relative market performance.
  • Business Model Transformation: Analysts highlight that Teladoc is transitioning from a cyclical direct-to-consumer telehealth model to a higher-margin, data-driven business-to-business healthcare platform, which could enhance its long-term profitability and market valuation.
  • Improved Financial Health: With improving EBITDA margins, positive free cash flow, and a stronger balance sheet, Teladoc is seen as entering a more scalable profitability phase, supporting potential future valuation re-ratings.
CNBC
9.5
04-30CNBC
Mixed Earnings Reports from Multiple Companies
  • Willis Towers Watson's Weak Performance: The insurer reported only 3% organic revenue growth in Q1, falling short of the 4.8% market expectation, leading to a 12% drop in stock price, despite adjusted earnings exceeding Wall Street forecasts, indicating potential growth challenges ahead.
  • Hertz Partners with Uber: Hertz's stock surged about 18% following the announcement of a partnership with Uber, where its new Oro Mobility unit will support Uber's robotaxi initiative, with services expected to launch in the San Francisco Bay area later this year, marking a strategic move into autonomous driving.
  • Altria's Earnings Beat Expectations: Altria reported adjusted earnings of $1.32 per share in Q1, surpassing the $1.25 consensus estimate, resulting in a stock increase of over 5%, while reaffirming its full-year adjusted earnings guidance, showcasing stability in the tobacco sector.
  • Carrier Global's Strong Results: Carrier Global's Q1 adjusted earnings reached 57 cents, exceeding the expected 51 cents, with revenue of $5.34 billion surpassing the $5.01 billion consensus, leading to an 11% stock increase, reflecting robust performance in the building and refrigeration markets.
stocktwits
7.0
04-30stocktwits
FDA Proposes Exclusion of Weight Loss Drug Ingredients
  • FDA Proposal: The U.S. Food and Drug Administration (FDA) has proposed to exclude Semaglutide and Tirzepatide from the 503B bulk list, limiting the compounding capabilities of outsourcing facilities, which may impact the market supply and accessibility of these drugs.
  • Insufficient Clinical Need: The FDA stated that after reviewing available data, it found no clear clinical need to allow compounding of these drugs from raw ingredients, emphasizing patient safety and medical necessity, which could lead to restrictions on the use of related medications.
  • Quality and Safety Concerns: The FDA has expressed concerns regarding the quality and safety of compounded weight-loss drugs, noting that these drugs are not reviewed by the FDA, which may pose risks such as improper storage, dosing errors, and counterfeit products, thereby affecting patient health.
  • Market Reaction: Following the FDA proposal, shares of Eli Lilly and Novo Nordisk rose by 9% and 5%, respectively, indicating increased market confidence in the FDA-approved drugs from these companies, while Hims & Hers and Teladoc Health saw slight declines, reflecting market concerns over compounded medications.
CNBC
2.0
04-30CNBC
Significant Premarket Trading Moves by Multiple Companies
  • Meta's CapEx Increase: Meta Platforms raised its full-year capital expenditure guidance to between $125 billion and $145 billion, causing a 9% drop in stock price due to heightened concerns over AI spending, which negatively impacts investor confidence.
  • Eli Lilly's Strong Performance: Eli Lilly's first-quarter earnings and revenue exceeded analyst expectations, leading to an almost 8% stock increase, while the company raised its full-year sales outlook to between $82 billion and $85 billion, indicating robust market demand.
  • Alphabet's Impressive Earnings: Alphabet reported first-quarter revenue of $109.9 billion, surpassing the $107.2 billion expected by analysts, resulting in a 7.4% stock increase, with Google Cloud revenue soaring 63% year-over-year, showcasing strong growth potential in its cloud business.
  • Royal Caribbean's Solid Results: Royal Caribbean's first-quarter adjusted earnings came in at $3.60 per share, exceeding the $3.20 expected by analysts, and despite slightly missing revenue expectations, the stock rose 7%, reflecting market confidence in its financial health.
seekingalpha
2.0
04-30seekingalpha
Stock Futures Slip as Geopolitical Tensions Resurface
  • Market Volatility: Stock futures slipped on Thursday morning as geopolitical tensions resurfaced, driving Brent crude to a four-year high, with investors reacting cautiously to reports of potential new military measures against Iran by the Trump administration, indicating market concerns over future uncertainties.
  • Qualcomm's Strong Performance: Qualcomm (QCOM) shares surged 13% after reporting FQ2 adjusted EPS of $2.65, exceeding expectations, despite a 3% year-over-year revenue decline to $10.6 billion; growth in automotive (+38%) and IoT (+9%) segments demonstrated the company's resilience in diversifying markets.
  • Carvana's Sustained Growth: Carvana (CVNA) shares rose 9% after reporting record revenue and adjusted EBITDA in Q1, with retail units sold climbing 40% to 187,393 and revenue jumping 52% to $6.43 billion, although rising costs led to margin declines, the company anticipates sequential growth in retail units and EBITDA in Q2.
  • Alphabet's Strong Results: Alphabet (GOOG) shares advanced 7% after delivering a Q1 revenue increase of 22% year-over-year to $109.9 billion, with net income soaring 81% to $62.6 billion; the cloud segment's 63% revenue growth highlighted ongoing momentum driven by AI, and the company raised its quarterly dividend by 5% to $0.22 per share, reinforcing confidence in cash flow strength.
seekingalpha
9.5
04-30seekingalpha
Teladoc Health Q1 2026 Earnings Call Insights
  • Financial Performance Exceeds Expectations: Teladoc reported Q1 2026 revenue of $614 million, surpassing analysts' expectations of $611 million, with adjusted EBITDA of $58 million, demonstrating the company's execution capabilities and market adaptability in integrated care.
  • Insurance Market Expansion: The rollout in the U.S. insurance market has exceeded expectations, now live in 30 states and Washington D.C., with over 6,000 credentialed providers and more than 150 million covered lives, which is expected to provide strong support for future revenue growth.
  • Optimistic Future Outlook: Teladoc anticipates 2026 consolidated revenue between $2.48 billion and $2.58 billion, with adjusted EBITDA ranging from $267 million to $306 million, reflecting management's confidence in future performance, particularly driven by BetterHelp's insurance business.
  • Operational Challenges and Responses: Despite pressures on BetterHelp's direct-to-consumer business, management emphasized addressing these through insurance expansion and disciplined marketing spend, while ensuring adequate therapist capacity to meet demand, highlighting the company's focus on operational capabilities.
Wall Street analysts forecast TDOC stock price to rise
15 Analyst Rating
Wall Street analysts forecast TDOC stock price to rise
3 Buy
12 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
7.50
Averages
8.91
High
12.00
Current: 0.000
sliders
Low
7.50
Averages
8.91
High
12.00
Citi
Neutral
maintain
$6 -> $7
AI Analysis
2026-05-05
Reason
Citi
Price Target
$6 -> $7
AI Analysis
2026-05-05
maintain
Neutral
Reason
Citi raised the firm's price target on Teladoc to $7 from $6 and keeps a Neutral rating on the shares post the Q' report. The firm cites BetterHelp's better than expected results for the target boost.
Stifel
Hold
to
Hold
downgrade
$6
2026-04-30
Reason
Stifel
Price Target
$6
2026-04-30
downgrade
Hold
to
Hold
Reason
Stifel lowered the firm's price target on Teladoc to $5.50 from $6 and keeps a Hold rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TDOC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Teladoc Health Inc (TDOC.N) is 303.03, compared to its 5-year average forward P/E of -1.26. For a more detailed relative valuation and DCF analysis to assess Teladoc Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.26
Current PE
303.03
Overvalued PE
87.06
Undervalued PE
-89.59

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
21.07
Current EV/EBITDA
9.07
Overvalued EV/EBITDA
43.25
Undervalued EV/EBITDA
-1.11

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.39
Current PS
0.49
Overvalued PS
5.36
Undervalued PS
-0.58

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best swing trades
Intellectia · 40 candidates
Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $5.00 - $18.00One Week Rise Prob: >= 70Monthly Average Dollar Volume: >= 1,500,000
Ticker
Name
Market Cap$
top bottom
TALK logo
TALK
Talkspace Inc
856.44M
ACRS logo
ACRS
Aclaris Therapeutics Inc
435.91M
PHIO logo
PHIO
Phio Pharmaceuticals Corp
14.64M
WTI logo
WTI
W&T Offshore Inc
424.02M
TURB logo
TURB
Turbo Energy SA
41.20M
OLN logo
OLN
Olin Corp
2.70B
what are some day trades i can do with 300$
Intellectia · 122 candidates
Region: USPrice: $1.00 - $30.00Price Change Pct: $3.00 - $100.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
UWMC logo
UWMC
UWM Holdings Corp
6.66B
PATH logo
PATH
UiPath Inc
5.32B
AAL logo
AAL
American Airlines Group Inc
8.80B
OPEN logo
OPEN
Opendoor Technologies Inc
4.77B
RGTI logo
RGTI
Rigetti Computing Inc
5.82B
LUNR logo
LUNR
Intuitive Machines Inc
3.23B

Whales Holding TDOC

T
Tang Capital Management, LLC
Holding
TDOC
+3.72%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Teladoc Health Inc (TDOC) stock price today?

The current price of TDOC is 7.21 USD — it has decreased -0.55

What is Teladoc Health Inc (TDOC)'s business?

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

What is the price predicton of TDOC Stock?

Wall Street analysts forecast TDOC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TDOC is8.91 USD with a low forecast of 7.50 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Teladoc Health Inc (TDOC)'s revenue for the last quarter?

Teladoc Health Inc revenue for the last quarter amounts to 613.85M USD, decreased -2.47

What is Teladoc Health Inc (TDOC)'s earnings per share (EPS) for the last quarter?

Teladoc Health Inc. EPS for the last quarter amounts to -0.36 USD, decreased -32.08

How many employees does Teladoc Health Inc (TDOC). have?

Teladoc Health Inc (TDOC) has 5600 emplpoyees as of May 11 2026.

What is Teladoc Health Inc (TDOC) market cap?

Today TDOC has the market capitalization of 1.31B USD.